Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  20,563 results for ""IDIOPATHIC pulmonary fibrosis""

Your Filters

Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Leech extract alleviates idiopathic pulmonary fibrosis by TGF-β1/Smad3 signaling pathway.

  • Authors : Zhang Y; Jiangsu Key Laboratory for High Technology Research of TCM Formulae, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, P. R. China.; Lu YB

Subjects: Transforming Growth Factor beta1*/Transforming Growth Factor beta1*/Transforming Growth Factor beta1*/metabolism ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/chemically induced ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/drug therapy

  • Source: Journal of ethnopharmacology [J Ethnopharmacol] 2024 Apr 24; Vol. 324, pp. 117737. Date of Electronic Publication: 2024 Jan 14.Publisher: Elsevier Sequoia Country of Publication: Ireland NLM ID: 7903310 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Combination of losartan with pirfenidone: a protective anti-fibrotic against pulmonary fibrosis induced by bleomycin in rats.

  • Authors : Amirkhosravi A; Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran.

Subjects: Losartan*/Losartan*/Losartan*/pharmacology ; Losartan*/Losartan*/Losartan*/therapeutic use ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/chemically induced

  • Source: Scientific reports [Sci Rep] 2024 Apr 16; Vol. 14 (1), pp. 8729. Date of Electronic Publication: 2024 Apr 16.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Revolutionizing the Treatment of Idiopathic Pulmonary Fibrosis: From Conventional Therapies to Advanced Drug Delivery Systems.

  • Authors : Singh S; Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai, 400056, Maharashtra, India.; Wairkar S

Subjects: Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/drug therapy ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/chemically induced ; Nanoparticles*

  • Source: AAPS PharmSciTech [AAPS PharmSciTech] 2024 Apr 08; Vol. 25 (4), pp. 78. Date of Electronic Publication: 2024 Apr 08.Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932

Record details

Read More Add to Saved list
×
Academic Journal

Association between statin use and the risk for idiopathic pulmonary fibrosis and its prognosis: a nationwide, population-based study.

  • Authors : Park J; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 101, Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.; Lee CH

Subjects: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/drug therapy ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/epidemiology

  • Source: Scientific reports [Sci Rep] 2024 Apr 02; Vol. 14 (1), pp. 7805. Date of Electronic Publication: 2024 Apr 02.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Idiopathic pulmonary fibrosis: Desperately seeking a model].

  • Authors : Hennion N; Inserm, U1286 - Infinite, Université de Lille, CHU de Lille, 59000 Lille, France.; Chenivesse C

Subjects: Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/diagnosis ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/therapy; Animals

  • Source: Revue des maladies respiratoires [Rev Mal Respir] 2024 Apr; Vol. 41 (4), pp. 274-278. Date of Electronic Publication: 2024 Mar 12.Publisher: Elsevier-Masson Country of Publication: France NLM ID: 8408032 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Identification of Idiopathic Pulmonary Fibrosis and Prediction of Disease Severity via Machine Learning Analysis of Comprehensive Metabolic Panel and Complete Blood Count Data.

  • Authors : Mueller AN; School of Medicine, University of Louisville, Louisville, KY, USA.; Miller HA

Subjects: Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/complications ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/diagnosis ; Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/etiology

  • Source: Lung [Lung] 2024 Apr; Vol. 202 (2), pp. 139-150. Date of Electronic Publication: 2024 Feb 20.Publisher: Springer Verlag Country of Publication: United States NLM ID: 7701875 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A novel model for predicting prognosis in patients with idiopathic pulmonary fibrosis based on endoplasmic reticulum stress-related genes.

  • Authors : Liu B; Department of Medical Aspects of Specifc Environments, School of Basic Medicine, Anhui Medical University, Hefei, China.; Zhang X

Subjects: Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/genetics ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/pathology; Humans

  • Source: Cell biology international [Cell Biol Int] 2024 Apr; Vol. 48 (4), pp. 483-495. Date of Electronic Publication: 2024 Jan 18.Publisher: Chichester Country of Publication: England NLM ID: 9307129 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-8355

Record details

Read More Add to Saved list
×
Academic Journal

Systemic scleroderma: Review and updated approach and case description to addressing pulmonary arterial hypertension and idiopathic pulmonary fibrosis: A dual challenge in treatment.

  • Authors : Cueto-Robledo G; Cardiorespiratory emergencies, General Hospital of México, Dr. Eduardo Liceaga, Mexico City 06720, Mexico; Pulmonary Circulation Clinic, Hospital General de México 'Dr Eduardo Liceaga', Mexico City 06720, Mexico

Subjects: Pulmonary Arterial Hypertension* ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/complications ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/diagnosis

  • Source: Current problems in cardiology [Curr Probl Cardiol] 2024 Apr; Vol. 49 (4), pp. 102404. Date of Electronic Publication: 2024 Jan 15.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7701802 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD.

  • Authors : Nathan SD; Advanced Lung Disease and Transplant Program, Inova Heart and Vascular Institute, Inova Fairfax Hospital, Falls Church, Virginia. Electronic address: .; Chandel A

Subjects: Hypertension, Pulmonary*/Hypertension, Pulmonary*/Hypertension, Pulmonary*/etiology ; Hypertension, Pulmonary*/Hypertension, Pulmonary*/Hypertension, Pulmonary*/complications ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/complications

  • Source: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation [J Heart Lung Transplant] 2024 Apr; Vol. 43 (4), pp. Publisher: Elsevier Country of Publication: United States NLM ID: 9102703 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effects of Anti-Fibrotic Drugs on Transcriptome of Peripheral Blood Mononuclear Cells in Idiopathic Pulmonary Fibrosis.

  • Authors : Ishii D; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.; Kawasaki T

Subjects: Plasminogen Activator Inhibitor 1* ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/drug therapy ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/genetics

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 28; Vol. 25 (7). Date of Electronic Publication: 2024 Mar 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read More Add to Saved list
×
  • 1-10 of  20,563 results for ""IDIOPATHIC pulmonary fibrosis""